Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 350,736 | 306,681 | 271,566 | 180,426 | 375,656 |
| Marketable Securities | 29,743 | 118,402 | 208,564 | 267,601 | 118,268 |
| Receivables | 4,022 | 3,409 | 2,988 | 2,844 | 2,407 |
| TOTAL | $411,215 | $455,481 | $506,264 | $474,289 | $512,316 |
| Non-Current Assets | |||||
| PPE Net | 622 | 667 | 711 | 722 | 581 |
| Other Non-Current Assets | 2,498 | 3,948 | 4,287 | 2,922 | 5,316 |
| TOTAL | $3,120 | $4,615 | $4,998 | $3,644 | $5,897 |
| Total Assets | $414,335 | $460,096 | $511,262 | $477,933 | $518,213 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 25,282 | 17,079 | 12,006 | 8,992 | 10,711 |
| Accrued Expenses | 21,587 | 8,732 | 10,543 | 12,099 | 7,926 |
| TOTAL | $48,368 | $27,361 | $23,981 | $22,463 | $20,081 |
| Non-Current Liabilities | |||||
| Long Term Debt | 73,741 | 73,381 | 73,022 | N/A | N/A |
| Other Non-Current Liabilities | 2,000 | 2,241 | 2,293 | 2,870 | 3,355 |
| TOTAL | $74,776 | $74,791 | $74,700 | $2,079 | $2,631 |
| Total Liabilities | $123,144 | $102,152 | $98,681 | $24,542 | $22,712 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,231 | 64,231 | 64,204 | 64,012 | 63,905 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -400,486 | -330,757 | -275,537 | -235,593 | -189,989 |
| Other shareholders' equity | 2,563 | 4,733 | 7,448 | 11,563 | 10,140 |
| TOTAL | $291,191 | $357,944 | $412,581 | $453,391 | $495,502 |
| Total Liabilities And Equity | $414,335 | $460,096 | $511,262 | $477,933 | $518,213 |